NASDAQ: GILDGilead Sciences Inc Stock Ownership - Who owns Gilead Sciences?
Insider buying vs selling
Have Gilead Sciences Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Merdad Parsey | Chief Medical Officer | 2023-03-13 | 6,126 | $78.99 | $483.89kSell |
| Johanna Mercier | Chief Commercial Officer | 2023-03-10 | 5,116 | $79.50 | $406.72kSell |
| Daniel Patrick Oday | Chairman CEO | 2023-03-10 | 14,017 | $79.50 | $1.11MSell |
| Andrew D. Dickinson | Chief Financial Officer | 2023-03-10 | 4,849 | $79.50 | $385.50kSell |
| Merdad Parsey | Chief Medical Officer | 2023-03-10 | 5,328 | $79.50 | $423.58kSell |
| Sandra Patterson | SVP Controllership | 2023-03-10 | 801 | $79.50 | $63.68kSell |
| Kevin E. Lofton | Director | 2023-03-09 | 8,442 | $52.38 | $442.19kBuy |
| Daniel Patrick Oday | Chairman CEO | 2023-03-01 | 4,842 | $79.59 | $385.37kSell |
| Merdad Parsey | Chief Medical Officer | 2023-03-01 | 12,984 | $79.96 | $1.04MSell |
| Merdad Parsey | Chief Medical Officer | 2023-02-15 | 376 | $56.38 | $21.20kBuy |
GILD insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when GILD insiders and whales buy or sell their stock.
GILD Shareholders
What type of owners hold Gilead Sciences Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Blackrock Inc | 10.55% | 131,560,250 | $10.92B | Institution |
| Vanguard Group Inc | 8.98% | 112,038,324 | $9.30B | Institution |
| Capital World Investors | 5.52% | 68,892,972 | $5.72B | Institution |
| State Street Corp | 4.73% | 58,941,373 | $4.89B | Institution |
| Capital Research Global Investors | 4.38% | 54,602,952 | $4.53B | Institution |
| Dodge Cox | 2.88% | 35,885,152 | $2.98B | Institution |
| Geode Capital Management LLC | 1.91% | 23,848,477 | $1.98B | Institution |
| Morgan Stanley | 1.38% | 17,196,950 | $1.43B | Institution |
| Bank Of New York Mellon Corp | 1.33% | 16,545,609 | $1.37B | Institution |
| Fmr LLC | 1.32% | 16,438,903 | $1.36B | Institution |
GILD vs General Drug Manufacturer Stocks
Gilead Sciences Stock Ownership FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.